Study of pharmacokinetics of prenylflavonoids and dynamics of estrogen action in sera following ingestion of epimedium using validated, ultra sensitive cell based bioassays 6

229
BIBLIOGRAPHY

Agatonovic-Kustrin, S., Turner, J.V. and Glass, B.D. 2008. Molecular structural
characteristics as determinants of estrogen receptor selectivity. J Pharm Biomed
Anal 48(2):369-75.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M.
and Fukami, Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein
kinases. J Biol Chem 262(12): 5592-5595.
Albertsson-Wikland, K., Rosberg, S., Lannering, B., Dunkel, L., Selstam, G. and
Norjavaara, E. 1997. Twenty-four-hour profiles of luteinizing hormone, follicle-
stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study
throughout puberty in healthy boys. J Clin Endocrinol Metab 82(2):541–549.
Andersen, H.R., Andersson, A.M., Arnold, S.F., Autrup, H., Barfoed, M., Beresford, N.A.,
Bjerregaard, P., Christiansen, L.B., Gissel, B., Hummel, R., Jorgensen, EB.,
Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Moller, A., Nielsen, J.B.,
Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K.L., Perez, P., Skakkeboek,
N.E., Sonnenschein, C., Soto, A.M, Sumpter, J.P., Thorpe, S.M. and Grandjean, P.
1999. Comparison of short-term estrogenicity tests for identification of hormone-
disrupting chemicals. Environ Health Perspect 107(suppl 1): 89-108.
Andrikoula, M. and Prelevic, G. 2009. Menopausal hot flushes revisited. Climacteric
12(1):3-15.
Androutsopoulos, V. P., Tsatsakis, A. M. and Spandidos, D. A. 2009a. Cytochrome P450
CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9: 187.
Androutsopoulos, V.P., Li, N. and Arroo, R.R. 2009b. The methoxylated flavones
eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells. J Nat Prod
72(8):1390-4.
Ascenzi, P., Bocedi, A. and Marino, M. 2006. Structure-function relationship of estrogen
receptor alpha and beta: impact on human health. Mol Aspects Med 27(4):299-402.
Ashida, H., Nishiumi, S. and Fukuda, I. 2008. An update on the dietary ligands of the

AhR. Expert Opin Drug Metab Toxicol 4(11):1429-47.
Atkinson Jr, A.J., Abernethy, D.R., Daniels, C.E. and Dedrick R. 2006. Principles of
Clinical Pharmacology (2
nd
Edition): 96-97.
Baber, R. 2010. Phytoestrogens and post reproductive health. Maturitas 66(4):344-9
Beck, V., Rohr, U. and Jungbauer, A. 2005. Phytoestrogens derived from red clover: an
alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol
94(5):499-518.

230
Benjamini, Yoav and Hochberg, Yosef. 1995. Controlling the false discovery rate: a
practical and powerful approach to multiple testing. J. Royal Stat Soc, Series B
(Methodological) 57(1): 289–300.
Blair, I.A. 2010. Analysis of estrogens in serum and plasma from postmenopausal women:
past present, and future. Steroids 75(4-5):297-306.
Bolli, A., Marino, M., Rimbach, G., Fanali, G., Fasano, M. and Ascenzi, P. 2010
Flavonoid binding to human serum albumin. Biochem Biophys Res Commun
398(3):444-9.
Boulton, D.W., Walle, U.K. and Walle, T. 1999. Fate of the flavonoid quercetin in human
cell lines: chemical instability and metabolism. J Pharm Pharmacol 51(3):353-9.
Bramlett, K.S. and Burris, T.P. 2003. Target specificity of selective estrogen receptor
modulators within human endometrial cells. J Steroid Biochem Mol Biol 86(1):27-
34.
Brown, C.M., Suzuki, S., Jelks, K.A. and Wi s e, P.M. 2009. Estradiol is a potent
protective, restorative, and trophic factor after brain injury. Semin Reprod Med
27(3):240-9.
Busby, M.G., Jeffcoat, A.R., Bloedon, L.T., Koch, M.A., Black, T., Dix, K.J., Heizer,
W.D., Thomas, B.F., Hill, J.M., Crowell, J.A. and Zeisel, S.H. 2002. Clinical
characteristics and pharmacokinetics of purified soy isoflavones: single-dose

administration to healthy men. Am J Clin Nutr 75(1):126-36.
Chen, K.M., Ge, B.F., Ma, H.P. and Zheng, R.L. 2004. The serum of rats administered
flavonoid extract from Epimedium sagittatum but not the extract itself enhances the
development of rat calvarial osteoblast-like cells in-vitro. Pharmazie 59(1):61-4.
Chen, K.M Ge, B.F., Ma, H.P., Liu, X.Y., Bai, M.H. and Wang, Y. 2005. Icariin, a
flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat
primary bone marrow stromal cells. Pharmazie 60(12):939-42.
Chen, K.M., Ge, B F, Liu, X.Y., Ma, P.H., Lu, M.B., Bai, M.H. and Wang, Y. 2007a.
Icariin inhibits the osteoclast formation induced by RANKL and macrophage-
colony stimulating factor in mouse bone marrow culture. Pharmazie 62(5):388-91.
Chen, K.M., Ma, H.P., Ge, B.F., Liu, X.Y., Ma, L.P., Bai, M.H. and Wang, Y. 2007b.
Icariin enhances the osteogenic differentiation of bone marrow stromal cells but has
no effects on the differentiation of newborn calvarial osteoblasts of rats. Pharmazie
62(10):785-9.
Chen, X.J., Guo, B.L., Li, S.P., Zhang, Q.W., Tu, P.F. and Wang, Y.T. 2007c.
Simultaneous determination of 15 flavonoids in Epimedium using pressurized
liquid extraction and high-performance liquid chromatography. J Chromatogr A
1163:96–104.

231
Chen, X. W., Garner, S. C. and Anderson, J. J. 2002. Isoflavones regulate interleukin-6
and osteoprotegerin synthesis during osteoblast cell differentiation via an
estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 295(2):417-
22.
Chen, Y., Zhao, Y.H., Jia, X.B. and Hu, M. 2008. Intestinal absorption mechanisms of
prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai
(Yin Yanghuo). Pharm Res 25(9):2190-9.
Ciolino, H.P. and Yeh, G.C. 1999. Inhibition of aryl hydrocarbon-induced cytochrome P-
450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol
56(4):760-7.

Ciolino, H.P., Daschner, P.J. and Yeh, G.C. 1999. Dietary flavonols quercetin and
kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1
transcription differentially. Biochem J 340 (Pt 3):715-22.
Ciolino, H.P., Wang, T.T. and Yeh, G.C. 1998. Diosmin and diosmetin are agonists of the
aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
Cancer Res 58(13):2754-60.
Clarke, B.L. and Khosla, S. 2010. Female reproductive system and bone. Arch Biochem
Biophys 503(1):118-28.
Craig, M.C. and Murphy, D.G. 2009. Alzheimer's disease in women. Best Pract Res Clin
Obstet Gynaecol 23(1):53-61.
Craig, M.C. and Murphy, D.G. 2010. Estrogen therapy and Alzheimer's dementia. Ann N
Y Acad Sci (In press).
Crozier, A., Jaganath, I.B. and Clifford, M.N. 2009. Dietary phenolics: chemistry,
bioavailability and effects on health. Nat Prod Rep 26(8):1001-43.
Crozier, A., Del Rio, D. and Clifford, M.N. 2010. Bioavailability of dietary flavonoids
and phenolic compounds. Mol Aspects Med (In press).
Day, A. J., Canada, F. J., Diaz, J. C., Kroon, P. A., Mclauchlan, W. R., Faulds, . B.,
Plumb, G. W., Morgan, M.R.A. & Williamson, G. 2000. Dietary flavonoid and
isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin
hydrolase. FEBS Lett 468(2-3): 166–170.
de Rijke, E., Out, P., Niessen, W.M., Ariese, F., Gooijer, C. and Brinkman, U.A. 2006.
Analytical separation and detection methods for flavonoids. J Chromatogr A.
1112(1-2):31-63.
Déchaud, H., Ravard, C., Claustrat, F., de la Perrière, A.B. and Pugeat, M. 1999.
Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG).
Steroids 64(5):328-34.
Denison, M.S. and Nagy, S.R. 2003. Activation of the aryl hydrocarbon receptor by
structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol
Toxicol 43:309-34.

232
Deroo, B.J. and Korach, K.S. 2006. Estrogen receptors and human disease. J Clin Invest
116(3): 561-70.
Dip, R., Lenz, S., Antignac, J.P., Le Bizec, B., Gmuender, H. and Naegeli, H. 2008.
Global gene expression profiles induced by phytoestrogens in human breast cancer
cells. Endocr Relat Cancer 15(1):161-73.
Donovan, J.L., Manach, C., Faulks, R.M., Kroon, P.A. 2006. Absorption and metabolism
of dietary secondary metabolites. In: Crozier, A., Clifford, M.N., Ashihara, H.
(Eds.), Plant Secondary Metabolites. Occurrence, Structure and Role in the Human
Diet. Blackwell Publishing, Oxford, New York, 303–351.
Dufour, C. and Dangles, O. 2004. Flavonoid-serum albumin complexation: determination
of binding constants and binding sites by fluorescence spectroscopy. Biochim
Biophys Acta 1721(1-3):164-73.
Düsterberg, B., Schmidt-Gollwitzer, M. and Hümpel. M. 1985. Pharmacokinetics and
biotransformation of estradiol valerate in ovariectomized women. Horm Res
21(3):145-54.
E.M. Agency, European Medicines Agency, 1995.
Escande, A., Pillon, A., Servant, N., Cravedi, J.P., Larrea, F., Muhn, P., Nicolas, J.C.,
Cavaillès, V. and Balaguer, P. 2006. Evaluation of ligand selectivity using reporter
cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol
71(10):1459-69.
Fabre, N., Rustan, I., de Hoffmann, E. and Quetin-Leclercq, J. 2001. Determination of
flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography
electrospray ion trap mass spectrometry. J Am Soc Mass Spectrom. 12(6):707-15.
Foryst-Ludwig, and Kintscher U. 2010. Metabolic impact of estrogen signalling through
ERalpha and ERbeta. J Steroid Biochem Mol Biol 122(1-3):74-81.
Freeman, E.W. and Sherif, K. 2007. Prevalence of hot flushes and night sweats around the
world: a systematic review. Climacteric 10(3):197-214.
Frigo, D.E., Duong, B.N., Melnik, L.I., Schief, L.S., Collins-Burow, B.M., Pace, D.K.,
McLachlan, J.A. and Burow, M.E. 2002. Flavonoid phytochemicals regulate

activator protein-1 signal transduction pathways in endometrial and kidney stable
cell lines. J Nutr 132(7): 1848–1853.
Fu, H.J., Jia, L.T., Bao, W., Zhao, J., Meng, Y.L., Wang, C.J., Yao, L.B., Chen, S.Y. and
Yang, A.G. 2006. Stable knockdown of estrogen receptor alpha by vector-based
RNA interference suppresses proliferation and enhances apoptosis in breast cancer
cells. Cancer Biol Ther 5(7):842-7.
Gee, J.M., DuPont, M.S., Rhodes, M.J. and Johnson, I.T. 1998. Quercetin glucosides
interact with the intestinal glucose transport pathway. Free Radic Biol Med,
25(1):19-25.

233
Gehm, B.D., Levenson, A.S., Liu, H., Lee, E.J., Amundsen, B.M., Cushman, M., Jordan,
V.C. and Jameson, J.L. 2004. Estrogenic effects of resveratrol in breast cancer
cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
J Steroid Biochem Mol Biol 88(3):223–234.
Gikas, P.D. and Mokbel, K. 2005. Phytoestrogens and the risk of breast cancer: a review
of the literature. Int J Fertil Womens Med 50(6):250-8.
Gold, E.B., Colvin, A., Avis, N., Bromberger, J., Greendale, G.A., Powell, L., Sternfeld,
B. and Matthews, K. 2006. Longitudinal analysis of the association between
vasomotor symptoms and race/ethnicity across the menopausal transition: study of
womens’ health across the nation. Am J Public Health 96(7):1226–35.
Gong, Y., Yip, S.C., Thamarai, S.K., Zhang, J., Lee, H.K. and Yong, E.L. 2007. Trace
analysis of icariin in human serum with dansyl chloride derivatization after oral
administration of Epimedium decoction by liquid chromatography tandem mass
spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 860:166–172.
Gruber, C.J., Tschugguel, W., Schneeberger, C. and Huber, J.C. 2002. Production and
actions of estrogens. N Engl J Med 346(5):340-52.
Gunderson, K.L., Kruglyak, S., Graige, M.S., Garcia, F., Kermani, B.G., Zhao, C., Che,
D., Dickinson, T., Wickham, E., Bierle, J., Doucet, D., Milewski, M., Yang, R.,
Siegmund, C., Haas, J., Zhou, L., Oliphant, A., Fan, J.B., Barnard, S. and Chee,

M.S. 2004. Decoding randomly ordered DNA arrays. Genome Res 14(5):870-7.
Hamers, T., Kamstra, J.H., Sonneveld, E., Murk, A.J., Kester, M.H., Andersson, P.L.,
Legler, J. and Brouwer, A. 2006. In vitro profiling of the endocrine-disrupting
potency of brominated flame retardants. Toxicol Sci 92(1):157-73.
Harris, D.M., Besselink, E., Henning, S.M., Go, V.L. and Heber, D. 2005. Phytoestrogens
induce differential estrogen receptor alpha- or beta-mediated responses in
transfected breast cancer cells. Exp Biol Med (Maywood) 230(8): 558–568.
Hawkins, M.B., Thornton, J.W., Crews, D., Skipper, J.K., Dotte, A. and Thomas, P. 2000.
Identification of a third distinct estrogen receptor and reclassification of estrogen
receptors in teleosts. Proc Natl Acad Sci USA 97(20):10751-6.
Hendrickson, H.P., Milesi-Hallé, A., Laurenzana, E.M. and Owens, S.M. 2004.
Development of a liquid chromatography-tandem mass spectrometric method for
the determination of methamphetamine and amphetamine using small volumes of
rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 806(2):81-7.
Hodgert Jury, H., Zacharewski, T.R. and Hammond, G.L. 2000. Interactions between
human plasma sex hormone-binding globulin and xenobiotic ligands. J Steroid
Biochem Mol Biol 75(2-3):167-76.
Ise, R., Han, D., Takahashi, Y., Terasaka, S., Inoue, A., Tanji, M. and Kiyama, R. 2005.
Expression profiling of the estrogen responsive genes in response to
phytoestrogens using a customized DNA microarray. FEBS Lett 579(7):1732-40.

234
Jaganath, I.B., Mullen, W., Edwards, C.A. and Crozier, A. 2006. The relative contribution
of the small and large intestine to the absorption and metabolism of rutin in man.
Free Rad Res 40(10) 1035–1046.
Jefcoate, C.R., Liehr, J.G., Santen, R.J., Sutter, T.R., Yager, J.D., Yue, W., Santner, S.J.,
Tekmal, R., D e m ers, L., Pauley, R., Naftolin, F., Mor, G. and Berstein, L. 2000.
Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer
Inst Monogr 27: 95–112.
Jiang, Y.N., Mo, H.Y. and Chen, J.M. 2002. Effects of Epimedium total flavonoids

phytosomes on preventing and treating bone-loss of ovariectomized rats.
Zhongguo Zhong Yao Za Zhi 27(3):221-4.
Jørgensen, M., Hummel, R., Bévort, M., Andersson, A.M., Skakkebaek, N.E. and Leffers,
H. 1998. Detection of oestrogenic chemicals by assaying the expression level of
oestrogen regulated genes. APMIS 106: 245-251.
Kaaja, R.J. 2008. Metabolic syndrome and the menopause. Menopause Int 14(1):21-5.
Kahle, K. Kraus, M., Scheppach, W. and Richling, E. 2005. Colonic availability of apple
polyphenols - a study in ileostomy subjects. Mol Nutr Food Res 49(12), 1143–1150.
Kahle, K., Kraus, M., Scheppach, W., Ackermann, M., Ridder, F. and Richling, E. 2006.
Studies on apple and blueberry fruit constituents: do the polyphenols reach the
colon after ingestion? Mol Nutr Food Res 50(4-5): 418–423.
Kano, M., Takayanagi, T., Harada, K., Sawada, S. and Ishikawa, F. 2006. Bioavailability
of isoflavones after ingestion of soy beverages in healthy adults. J Nutr
136(9):2291-6.
Kanaze, F.I., Bounartzi, M.I., Georgarakis, M. and Niopas, I. 2007. Pharmacokinetics of
the citrus flavanone aglycones hesperetin and naringenin after single oral
administration in human subjects. Eur J Clin Nutr 61(4):472-7.
Klinge, C.M. 2000. Estrogen receptor interaction with co-activators and co-repressors.
Steroids 65(5):227-51.
Knight, D.C. and Eden, J.A. 1996. A review of the clinical effects of phytoestrogens.
Obstet Gynecol 87(5 Pt 2): 897-904.
Korde, L.A., Wu, A.H., Fears, T., Nomura, A.M., West, D.W., Kolonel, L.N., Pike, M.C.,
Hoover, R.N. and Ziegler, R.G. 2009. Childhood soy intake and breast cancer risk
in Asian American women. Cancer Epidemiol Biomarkers Prev 18(4):1050-9.
Kretzschmar, G., Zierau, O., Wober, J., Tischer, S., Metz, P. and Vollmer, G. 2010.
Prenylation has a compound specific effect on the estrogenicity of naringenin and
genistein. J Steroid Biochem Mol Biol 118(1-2):1-6.
Kuhn, K., Baker, S.C., Chudin, E., Lieu, M.H., Oeser, S., Bennett, H., Rigault, P., Barker,
D., McDaniel, T.K. and Chee, M.S. 2004. A novel, high-performance random
array platform for quantitative gene expression profiling. Genome Res

14(11):2347-56.

235
Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S. and
Gustafsson, J.A. 1997. Comparison of the ligand binding specificity and transcript
tissue distribution of estrogen receptors alpha and beta. Endocrinology
138(3):863–870.
Kuhl, H. 2005. Pharmacology of estrogens and progestogens: influence of different routes
of administration. Climacteric Suppl 1:3-63.
Kuo, M.L. and Yang, N.C. 1995. Reversion of v-H-ras-transformed NIH 3T3 cells by
apigenin through inhibiting mitogen activated protein kinase and its downstream
oncogenes. Biochem Biophys Res Commun 212(3): 767-775.
Kurzer, M.S. and Xu, X. 1997. Dietary phytoestrogens. Annu Rev Nutr 117: 353-381.
Lagari, V.S. and Levis, S. 2010. Phytoestrogens and bone health. Curr Opin Endocrinol
Diabetes Obes 17(6):546-53.
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J.,
Brunet, J. P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G.,
Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S.
and Golub, T. R. 2006. The connectivity map: using gene-expression signatures to
connect small molecules, genes, and disease. Science 313: 1929-1935.
Lambert, J.D., Hong, J., Kim, D.H., Mishin, V.M. and Yang, C.S. 2004. Piperine
enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in
mice. J Nutr 134(8):1948-52.
Lampe J,W. and Chang, J.L. 2007. Interindividual differences in phytochemical
metabolism and disposition. Semin Cancer Biol. 17(5):347-53.
Le Bail, J.C., Varnat, F., Nicolas, J.C. and Habrioux, G. 1998. Estrogenic and
antiproliferative activities on MCF-7 human breast cancer cells by flavonoids.
Cancer Lett 130:209–216.
Legler, J., van den Brink, C.E., Brouwer, A., Murk, A.J., van der Saag, P.T., Vethaak,
A.D. and van der Burg, B. 1999. Development of a stably transfected estrogen

receptor-mediated luciferase reporter gene assay in the human T47D breast cancer
cell line. Toxicol Sci 48:55–66.
Lethaby, A.E., Brown, J., Marjoribanks, J., Kronenberg, F., Roberts, H. and Eden, J. 2007.
Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev
17(4):CD001395.
Leung, L.K., Po, L.S., Lau, T.Y. and Yuen, Y.M. 2004. Effect of dietary flavonols on
oestrogen receptor transactivation and cell death induction. Br J Nutr 91(6):831–
839.
Levin, E.R. 2009. Plasma membrane estrogen receptors. Trends Endocrinol Metab 20(10),
477–482.


236
Li, J., Lee, L., Gong, Y., Shen, P., Wong, S.P., Wise, S.D. and Yong, E.L. 2009.
Bioassays for estrogenic activity: development and validation of estrogen receptor
(ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum
estrogenic activity in clinical studies. Assay Drug Dev Technol 7(1):80-9.
Li, Shi Zhen. c. 1500. Ben Cao Gang Mu. Xue Yuan Publishing House, Beijing
(published in 1991).
Li, J., Yu, S., Li, T. and Pang, S. 2002. In vitro study of the effects of Epimedium on
osteoclastic bone resorption in various oral mineralized tissues. Zhonghua Kou
Qiang Yi Xue Za Zhi. 37(5):391-4.
Liao, H.J., Chen, X.M. and Li, W.G. 1995. Effect of Epimedium sagittatum on quality of
life and cellular immunity in patients of hemodialysis maintenance. Zhongguo
Zhong Xi Yi Jie He Za Zhi 15(4):202-4. Chinese.
Lindegårdh, N., Hanpithakpong, W., Wattanagoon, Y., Singhasivanon, P., White, N.J.
and Day, N.P. 2007. Development and validation of a liquid chromatographic-
tandem mass spectrometric method for determination of oseltamivir and its
metabolite oseltamivir carboxylate in plasma, saliva and urine. J Chromatogr B
Analyt Technol Biomed Life Sci 859(1):74-83.

Liu, A.R. and Xu, L.X. 1984. Analysis of active ingredients in traditional Chinese herbal
drugs. Assay of icariin in Epimedium. Chin J Pharm Anal 4: 81-84.
Liu, J. and Lou, Y.J. 2004. Determination of icariin and metabolites in rat serum by
capillary zone electrophoresis: rat pharmacokinetic studies after administration of
icariin. J Pharm Biomed Anal 36(2):365-70.
Liu, J., Ho, S.C., Su, Y.X., Chen, W.Q., Zhang, C.X. and Chen, Y.M. 2009. Effect of
long-term intervention of soy isoflavones on bone mineral density in women: a
m e ta-analysis of randomized controlled trials. Bone 44(5):948–953.
Liu, J., Ye, H. and Lou, Y. 2005. Determination of rat urinary metabolites of icariin in
vivo and estrogenic activities of its metabolites on MCF-7 cells. Pharmazie
60(2):120-5.
Liu, Z. and Hu, M. 2007. Natural polyphenol disposition via coupled metabolic pathways.
Expert Opin Drug Metab Toxicol 3(3):389-406.
Ma, D.F., Qin, L.Q., Wang, P.Y. and Katoh, R. 2008. Soy isoflavone intake increases
bone mineral density in the spine of menopausal women: meta-analysis of
randomized controlled trials. Clin Nutr 27(1):57–64.
Ma, Y., Li, P., Chen, D., Fang, T., Li, H. and Su, W. 2006. LC/MS/MS quantitation assay
for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma.
Int J Pharm 307(2):292-9.

237
Ma, Z., Wang, R. and Qiu, M. 1999. Study of morphologic effects of 4 Chinese herbs by
bone histomorphometry in ovariectomized rats. Zhonghua Fu Chan Ke Za Zhi
34(2):82-85.
Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A.G., Sisci, D., Pezzi, V.,
Montanaro, D., Musti, A.M., Picard, D. and Andò, S. 2004. The G protein-coupled
receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and
phytoestrogens in breast cancer cells. J Biol Chem 279(26): 27008–27016.
Mak, P., Cruz, F.D. and Chen, S. 1999. A yeast screen system for aromatase inhibitors
and ligands for androgen receptor: yeast cells transformed with aromatase and

androgen receptor. Environ Health Perspect 107(11):855-60.
Margeat, E., Bourdoncle, A., Margueron, R., Poujol, N., Cavailles, V. and Royer, C. 2003
Ligands differentially modulate the protein interactions of the human estrogen
receptors alpha and beta. J Mol Biol 326(1):77–92.
Markou, A., Dukam T. and Prelevic, G.M. 2005. Estrogens and brain function. Hormones
(Athens) 4(1):9-17.
Marks, S.C., Mullen, W., Borges, G. and Crozier, A.J. 2009. Absorption, metabolism, and
excretion of cider dihydrochalcones in healthy humans and subjects with an
ileostomy. Agric Food Chem 57(5):2009-15.
Masukawa, Y., Matsui, Y., Shimizu, N., Kondou, N., Endou, H., Kuzukawa, M., Hase, T.
2006. Determination of green tea catechins in human plasma using liquid
chromatography-electrospray ionization mass spectrometry. J Chromatogr B
Analyt Technol Biomed Life Sci 834(1-2):26-34.
Matuszewski, B.K., Constanzer, M.L. and Chavez-Eng, C.M. 2003. Strategies for the
Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on
HPLC−MS/MS. Anal Chem 75: 3019-30.
Meng, F.H., Li, Y.B., Xiong, Z.L., Jiang, Z.M. and Li, F.M. 2005. Osteoblastic
proliferative activity of Epimedium brevicornum Maxim. Phytomedicine
12(3):189-93.
Messina, M., W. McCaskill-Stevens and J. W. Lampe 2006. Addressing the soy and
breast cancer relationship: review, commentary, and workshop proceedings. J Natl
Cancer Inst 98(18): 1275-84.
Messina, M. and Hilakivi-Clarke, L. 2009. Early intake appears to be the key to the
proposed protective effects of soy intake against breast cancer. Nutr Cancer
61(6):792–8.
Messina, M. and Wu , A.H. 2009. Perspectives on the soy-breast cancer relation. Am J
Clin Nutr 89(5):S1673–9.


238

Milligan, S.R., Kalita, J.C., Pocock, V., Van De Kauter, V., Stevens, J.F., Deinzer, M.L.,
Rong, H. and De Keukeleire, D. 2000. The endocrine activities of 8-
prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin
Endocrinol Metab 85(12):4912-5.
Missmer, S.A., Eliassen, A.H., Barbieri, R.L. and Hankinson, S.E. 2004. Endogenous
estrogen, androgen, and progesterone concentrations and breast cancer risk among
postmenopausal women. J Natl Cancer Inst 96(24):1856-65.
Miyoshi, Y., Tanji, Y., Taguchi, T., Tamaki, Y. and Noguchi, S. 2003. Association of
serum estrone levels with estrogen receptor-positive breast cancer risk in
postmenopausal Japanese women. Clin Cancer Res 9(6):2229–2233.
Montani, C., Penza, M., Jeremic, M., Biasiotto, G., La Sala, G., De Felici, M., Ciana, P.,
Maggi, A. and Di Lorenzo, D. 2008. Genistein is an efficient estrogen in the
whole-body throughout mouse development. Toxicol Sci 103(1):57-67.
Moon, Y.J. and Morris, M.E. 2007. Pharmacokinetics and bioavailability of the
bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A
disposition in rats. Mol Pharm 4(6):865-72.
Mueller, S.O. 2002. Overview of in vitro tools to assess the estrogenic and antiestrogenic
activity of phytoestrogens. J Chrom B 777: 155-165.
Müller, C., Schäfer, P., Störtzel, M., Vogt, S. and Weinmann, W. 2002. Ion suppression
effects in liquid chromatography-electrospray-ionisation transport-region collision
induced dissociation mass spectrometry with different serum extraction methods
for systematic toxicological analysis with mass spectra libraries. J Chromatogr B
Analyt Technol Biomed Life Sci 773(1):47-52.
Nebert, D.W., Dalton, T.P., Okey, A.B. and Gonzalez, F.J. 2004. Role of aryl
hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental
toxicity and cancer. J Biol Chem 279(23):23847–50.
Nelson, R.E., Grebe, S.K., O’Kane, D.J. and Singh, R.J. 2004. Liquid chromatography-
tandem mass spectrometry assay for simultaneous measurement of estradiol and
estrone in human plasma. Clin Chem 50:373–384.
Nguyen, L.P. and Bradfield, C.A. 2008. The search for endogenous activators of the aryl

hydrocarbon receptor. Chem Res Toxicol 21(1):102–16.
Nichenametla, S. N., T. G. Taruscio, D. L. Barney and J. H. Exon 2006. A review of the
effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 46(2):
161-83.
Nilsson, S. and Gustafsson, J Å. 2010. Estrogen receptors: their actions and functional
roles in health and disease. In Nuclear Receptors: Current Concepts and Future
Challenges (eds. Bunce, C. & Campbell, M.J.) 91–141 (Springer, The Netherlands).
Nowell, S. and Falany, C.N. 2006. Pharmacogenetics of human cytosolic
sulfotransferases. Oncogene. 25(11):1673-8.

239
Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S.,
Kouzmenko, A., Nohara, K., Chiba, T., Fujii-Kuriyama, Y. and Kato, S. 2007.
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446(7135):562–6
Ohtake, F., Fujii-Kuriyama, Y. and Kato, S. 2009. AhR acts as an E3 ubiquitin ligase to
modulate steroid receptor functions. Biochem Pharmacol 77(4):474-84.
Ozers, M.S., Ervin, K.M., Steffen, C.L., Fronczak, J.A., Lebakken, C.S., Carnahan, K.A.,
Lowery, R.G. and Burke, T.J. 2005. Analysis of ligand-dependent recruitment of
coactivator peptides to estrogen receptor using fluorescence polarization. Mol
Endocrinol 19(1):25–34.
Paris, F., Servant, N., Terouanne, B., Balaguer, P., Nicolas, J.C. and Sultan, C. 2002. A
new recombinant cell bioassay for ultrasensitive determination of serum
estrogenic bioactivity in children. J Clin Endocrinol Metab 87:791–797.
Pasqualini, J.R. 2005. Enzymes involved in the formation and transformation of steroid
hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol
97(5):401-15.
Peng, G., Fu, M. and Zhang, D. 1997. The experimental study about the relations between
Chinese herb - Epimedium leptorrhizum Stearn (CH-ELS) and endogenous cAMP
in alveolar bone of orthodontic tooth in rats. Zhonghua Kou Qiang Yi Xue Za Zhi
32(1): 40-42.

Peng, S., Xia, R., Fang, H., Li, F., Chen, A., Zhang, G. and Qin, L. 2008. Effect of
Epimedium-derived phytoestrogen on bone turnover and bone microarchitecture in
OVX-induced osteoporotic rats. J Huazhong Univ Sci Technolog Med Sci
28(2):167-70.
Penza, M., Montani, C., Romani, A., Vignolini, P., Ciana, P., Maggi, A., Pampaloni, B.,
Caimi, L. and Di Lorenzo, D. 2007. Genistein accumulates in body depots and is
mobilized during fasting, reaching estrogenic levels in serum that counter the
hormonal actions of estradiol and organochlorines. Toxicol Sci 97(2):299-307.
Poulsen, R.C. and Kruger, M.C. 2008. Soy phytoestrogens: impact on postmenopausal
bone loss and mechanisms of action. Nutr Rev 66(7):359-74.
Prasain, J.K., Wang, C.C. and Barnes, S. 2004. Mass spectrometric methods for the
determination of flavonoids in biological samples. Free Radic Biol Med
37(9):1324-50.
Qin, L., Han, T., Zhang, Q., Cao, D., Nian, H., Rahman, K. and Zheng, H. 2008.
Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional
Chinese herbal formula. J Ethnopharmacol 118(2):271-9.
Qiu, F., Chen, Y.J., Kano, Y.H. and Yao, X.S. 1999. Metabolism of orally administrated
icariin in rats. Acta Pharmaceutica Sinica 34(3): 222–226.
Rabe-Hesketh, S.A. and Pickles, A. 2002. Reliable estimation of generalized linear mixed
models using adaptive quadrature. Stata J 2:1–21.

240
Roowi, S., Stalmach, A., Mullen, W., Lean, M.E.J., Edwards, C.A. and Crozier, A. 2010.
Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by
humans. J Agric Food Chem 58(2): 1296–1304.
Rosano, C., Stec-Martyna, E., Lappano, R. and Maggiolini, M. 2011. Structure-Based
Approach for the Discovery of Novel Selective Estrogen Receptor Modulators.
Curr Med Chem (In press).
Sarkar, A.K., Ghosh, D., Das, A., Selvan, P.S., Gowda, K.V., Mandal, U., Bose, A.,
Agarwal, S., Bhaumik, U. and Pal, T.K. 2008. Simultaneous determination of

metoprolol succinate and amlodipine besylate in human plasma by liquid
chromatography–tandem mass spectrometry method and its application in
bioequivalence study. J Chromatogr B Anal Technol Biomed Life Sci 873(1): 77-
85.
Schaefer, O., Hümpel, M., Fritzemeier, K.H., Bohlmann, R. and Schleuning, W.D. 2003.
8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops
and beer. J Steroid Biochem Mol Biol 84(2-3):359-60.
Scrimshaw, M.D. and Lester, J.N. 2004. In-vitro assays for determination of oestrogenic
activity. Analyt. Biochem 378(3): 576-581.
Shah, V.P., Midha, K.K., Findlay, J.W., Hill, H.M., Hulse, J.D., McGilveray, I.J., McKay,
G., Miller, K.J., Patnaik, R.N., Powell, M.L., Tonelli, A., Viswanathan, C.T. and
Yacobi. A. 2000. Bioanalytical Method Validation—A Revisit with a Decade of
Progress. Pharm Res 17: 1551-7.
Shen, P., Guo, B.L., Gong, Y., Hong, D.Y., Hong, Y. and Yong, E.L. 2007. Taxonomic,
genetic, chemical and estrogenic characteristics of Epimedium species.
Phytochemistry 68:1448–1458.
Shen, P., Wong, S.P., Li, J. and Yong, E.L. 2009. Simple and sensitive liquid
chromatography–tandem mass spectrometry assay for simultaneous measurement
of five Epimedium prenylflavonoids in rat sera. J Chromatogr B 877(1-2): 71–78.
Shukla, S., MacLennan, G. T., Flask, C. A., Fu, P., Mishra, A., Resnick, M. I. and Gupta,
S. 2007. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses
prostate carcinogenesis in TRAMP mice. Cancer Res 67(14): 6925–6935.
Silberberg, M., Morand, C., Mathevon, T., Besson, C., Manach, C., Scalbert, A. and
Remesy, C. 2006. The bioavailability of polyphenols is highly governed by the
capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J
Nutr 45(2):88-96.
Sonneveld, E., Jansen, H.J., Riteco, J.A., Brouwer, A. and van der Burg, B. 2005.
Development of androgen- and estrogen-responsive bioassays, members of a panel
of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci
83(1):136-48.

Sonneveld, E., Ritecom J.A., Jansen, H.J., Pieterse, B., Brouwer, A., Schoonen, W.G.,
van der Burg, B. 2006. Comparison of in vitro and in vivo screening models for
androgenic and estrogenic activities. Toxicol Sci 89:173–187.

241
Stalmach, A., Mullen, W., Steiling, H., Williamson, G., Lean, M.E.J. and Crozier, A.
2010. Absorption, metabolism, and excretion of green tea flavan-3-ols in humans
with an ileostomy. Mol Nutr Food Res 54(3): 323–334.
Steemers, F.J. and Gunderson, K.L. 2005. Illumina, Inc. Pharmacogenomics 6(7):777-82.
Taku, K., Melby, M.K., Kurzer, M.S., Mizuno, S., Watanabe, S. and Ishimi, Y. 2010.
Effects of soy isoflavone supplements on bone turnover markers in menopausal
women: systematic review and meta-analysis of randomized controlled trials. Bone
47(2):413-23.
Takumi, H., Mukai, R., Ishiduka, S., Kometani, T. and Terao, J. 2011. Tissue distribution
of hesperetin in rats after a dietary intake. Biosci Biotechnol Biochem 75(8):1608-10.
Tan, X. and Weng, W. 1998. Efficacy of epimedium compound pills in the treatment of
the aged patients with kidney deficiency syndrome of ischemic cardio-cerebral
vascular diseases. Hunan Yi Ke Da Xue Xue Bao 23(5):450-452.Chinese.
Taylor, J.I., Grace, P.B. and Bingham, S.A. 2005. Optimization of conditions for the
enzymatic hydrolysis of phytoestrogen conjugates in urine and plasma. Anal
Biochem. 341(2): 220–229.
Tempfer, C.B., Froese, G., Heinze, G., Bentz, E.K., Hefler, L.A. and Huber, J.C. 2009.
Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med
122(10):939-46.e9.
Tiong, C.T. 2010. Dual activation of estrogen receptor α and aryl hydrocarbon receptor by
the prenylflavone, icaritin, restricts breast cancer cell growth and destabilizes
estrogen receptor α protein.

(Master’s Thesis),
Trock, B.J., Hilakivi-Clarke, L. and Clarke, R. 2006. Meta-analysis of soy intake and

breast cancer risk. J Natl Cancer Inst 98(7):459-71.
Trzeciakiewicz, A., Habauzit, V., Mercier, S., Barron, D., Urpi-Sarda, M., Manach, C.,
Offord, E. and Horcajada, M.N. 2010. Molecular mechanism of hesperetin-7-O-
glucuronide, the main circulating metabolite of hesperidin, involved in osteoblast
differentiation. J Agric Food Chem. 58(1):668-75.
U.S. Food and Drug Administration. 1996. Guidance for Industry: ICH Q2B Validation of
Analytical Procedures: Methodology.
U.S. Food and Drug Administration. 2005. Guidance for Industry: Estimating the
Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult
Healthy Volunteers.
Usui, T. 2006. Pharmaceutical prospects of phytoestrogens. Endocr J 53(1):7–20.
van den Beld, A.W., de Jong, F.H., Grobbee, D.E., Pols, H.A. and Lamberts, S.W. 2000.
Measures of bioavailable serum testosterone and estradiol and their relationships
with muscle strength, bone density, and body composition in elderly men. J Clin
Endocrinol Metab 85(9):3276–3282.

242
Vatanparast, H. and Chilibeck, P.D. 2007. Does the effect of soy phytoestrogens on bone
in postmenopausal women depend on the equol-producing phenotype? Nutr Rev
65(6 Pt 1):294-9.
Vaya, J. and Tamir, S. 2004. The relation between the chemical structure of flavonoids
and their estrogen-like activities. Curr Med Chem 11(10):1333-43.
Vree, T.B. and Timmer, C.J. 1998. Enterohepatic cycling and pharmacokinetics of
estradiol in post-menopausal women. J Pharm Pharmacol 50(8):857–864.
Walle, T., Otake, Y., Brubaker, J.A., Walle, U.K. and Halushka, P.V. 2001. Disposition
and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin
Pharmacol 51(2):143-6.
Walle, T., Browning, A.M., Steed, L.L., Reed, S.G. and Walle, U.K. 2005. Flavonoid
glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr
135(1):48-52.

Wang, B., Quan, J. and Guo, S. 2000. Effects of Epimedium on the expression of
interleukin-6 messenger ribonucleic acid in bone of ovariectomized rat. Zhonghua
Fu Chan Ke Za Zhi 35(12): 724-726.
Wang, S., Paris, F., Sultan, C.S., Song, R.X., Demers, L.M., Sundaram, B., Settlage, J.,
Ohorodnik, S. and Santen, R.J. 2005. Recombinant cell ultrasensitive bioassay for
measurement of estrogens in postmenopausal women. J Clin Endocrinol Metab
90:1407–1413.
Wang, Z.Q., Weber, N., Lou, Y.J. and Proksch, P. 2006. Prenylflavonoids as nonsteroidal
phytoestrogens and related structure-activity relationships. ChemMedChem
1(4):482-8.
Williams, C., Edvardsson, K., Lewandowski, S.A., Ström, A. and Gustafsson, J.A. 2008.
A genome-wide study of the repressive effects of estrogen receptor beta on estrogen
receptor alpha signaling in breast cancer cells. Oncogene 27(7):1019-32.
Williamson, G. and Manach, C. 2005. Bioavailability and bioefficacy of polyphenols in
humans. II. Review of 93 intervention studies. Am J Clin Nutr 81(1 Suppl):243S–
255S.
Wilson, V.S., Bobseine, K. and Gray, L.E. Jr. 2004. Development and Characterization of
a Cell Line that Stably Expresses an Estrogen-Responsive Luciferase Reporter for
the Detection of Estrogen Receptor Agonist and Antagonists. Toxicol Sci 81(1):
69-77.
Wong, S.P., Shen, P., Lee, L., Li, J. and Yong, E.L. 2009. Pharmacokinetics of
prenylflavonoids and correlations with the dynamics of estrogen action in sera
following ingestion of a standardized Epimedium extract. J Pharm Biomed Anal
50(2):216-23.
Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R. and Safe,
S. 2003. The aryl hydrocarbon receptor mediates degradation of estrogen receptor
α through activation of proteasomes. Mol Cell Biol 23(6):1843–55

243
Wu, H., Lien, E.J. and Lien, L.L. 2003. Chemical and pharmacological investigations of

Epimedium species: a survey. Prog Drug Res 60:1-57.
Wu, T., Cui, L., Zhang, Z., Chen, Z., Li, Q., Liao, J. and Huang, L. 1996. Experimental
study on antagonizing action of herba Epimedii on side effects induced by
glucocorticoids. Zhongguo Zhong Yao Za Zhi 21(12): 748-751.Wu, H., Lien, E.J.
and Lien, L.L. 2003. Chemical and pharmacological investigations of Epimedium
species: a survey. Prog Drug Res 60:1-57.
Wuttke, W., Jarry, H., Westphalen, S., Christoffel, V. and Seidlová-Wuttke, D. 2002.
Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol
83(1-5):133-47.
Xiao, Q., Chen, A. and Guo, F. 2005. Effects of Icariin on expression of OPN mRNA and
type I collagen in rat osteoblasts in vitro. J Huazhong Univ Sci Technolog Med Sci
25(6):690-2.
Xiao, J., Chen, T., Cao, H., Chen, L. and Yang, F. 2011a. Molecular property-affinity
relationship of flavanoids and flavonoids for HSA in-vitro. Mol Nutr Food Res
55(2):310-7.
Xiao, J., Zhao, Y., Wang, H., Yuan, Y., Yang, F., Zhang, C. and Yamamoto, K. 2011b.
Noncovalent interaction of dietary polyphenols with common human plasma
proteins. J Agric Food Chem 59(19):10747-54.
Xu, W., Zhang, Y., Yang, M., Shen, Z., Zhang, X., Zhang, W. and Li, H. 2007. LC-
MS/MS method for the simultaneous determination of icariin and its major
m e tabolites in rat plasma. J Pharm Biomed Anal 45(4):667-72.
Yager, J.D. and Davidson, N.E. 2006. Estrogen carcinogenesis in breast cancer. N Engl J
Med 354(3):270–82.
Yap, S.P. and Yong, E.L. 2005. Chapter 10: Epimedium species in HERBAL MEDICINES:
Molecular basis of biological activity. Volume Editors: Packer et al. Pg 229-246.
Yap, S.P., Shen, P., Butler, M.S., Gong, Y., Loy, C.J. and Yong, E.L. 2005. New
estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of
breast cancer cells. Planta Med 71(2):114-9.
Yap, S.P., Shen, P., Li, J., Lee, L.S. and Yong, E.L. 2007. Molecular and
pharmacodynamic properties of estrogenic extracts from the traditional Chinese

medicinal herb, Epimedium. J Ethnopharmacol 113(2):218-24.
Ye, H.Y. and Lou, Y.J. 2005. Preparation of two derivatives from icariin and
investigation of their estrogen-like effects. Phytomedicine 12(10):735-41 7.
Ye, H.Y., Liu, J. and Lou, Y.J. 2005. Preparation of two derivatives from icariin and
investigation of their estrogen-like effects. Zhejiang Da Xue Xue Bao Yi Xue Ban
34(2):131-6.
Yin, X.X., Chen, Z.Q., Dang, G.T., Ma, Q.J. and Liu, Z.J. 2005. Effects of Epimedium
pubescens icariine on proliferation and differentiation of human osteoblasts.
Zhongguo Zhong Yao Za Zhi. 30(4):289-91.

244
Yin, X.X., Chen, Z.Q., Liu, Z.J., Ma, Q.J. and Dang, G.T. 2007. Icariine stimulates
proliferation and differentiation of human osteoblasts by increasing production of
bone morphogenetic protein 2. Chin Med J (Engl) 120(3):204-10.
Yong, E.L., Wong, S.P., Shen, P., Gong, Y.H., Li, J. and Hong, Y. 2007. Standardization
and evaluation of botanical mixtures: lessons from a traditional Chinese herb,
Epimedium, with oestrogenic properties. Novartis Found Symp 282:173-88;
discussion 188-91, 212-8.
Yu, S., Chen, K., Li, S. and Zhang, K. 1999. In vitro and in vivo studies of the effect of a
Chinese herb medicine on osteoclastic bone resorption. Chin J Dent Res 2(1): 7-11.
Zava, D.T. and Duwe, G. 1997. Estrogenic and antiproliferative properties of genistein
and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27(1):31–
40.
Zhang, G., Qin, L., Hung, W.Y., Shi, Y.Y., Leung, P.C., Yeung, H.Y. and Leung, K.S.
2006. Flavonoids derived from herbal Epimedium brevicornum Maxim prevent
OVX-induced osteoporosis in rats independent of its enhancement in intestinal
calcium absorption. Bone 38(6):818-25.
Zhang, G., Qin, L. and Shi, Y. 2007a. Epimedium-derived phytoestrogen flavonoids exert
beneficial effect on preventing bone loss in late postmenopausal women: a 24-
month randomized, double-blind and placebo-controlled trial. J Bone Miner Res

22(7):1072-9.
Zhang, L., Zuo, Z. and Lin, G. 2007b. Intestinal and hepatic glucuronidation of flavonoids.
Mol Pharm 4(6):833-45. Zhang, G., Qin, L., Hung, W.Y., Shi, Y.Y., Leung, P.C.,
Yeung, H.Y. and Leung, K.S. 2006. Flavonoids derived from herbal Epimedium
brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its
enhancement in intestinal calcium absorption. Bone 38(6):818-25.\
Zhao, L.N. 2003. Clinical evaluation of the preventive efficacy of Epimedium on
Osteoporosis. Modern Journal of Integrated Chinese and Western Medicine
12(9);922-923.
Zhao, H.Y., Sun, J.H., Fan, M.X., Fan, L., Zhou, L., Li, Z., Han, J., Wang, B.R. and Guo,
D.A. 2008. Analysis of phenolic compounds in Epimedium plants using liquid
chromatography coupled with electrospray ionization mass spectrometry. J
Chromatogr A 1190(1-2):157-81.
Zhou, S., Hu, Y., Zhang, B., Teng, Z., Gan, H., Yang, Z., Wang, Q., Huan, M. and Mei, Q.
2008. Dose-dependent absorption, metabolism, and excretion of genistein in rats. J
Agric Food Chem 56(18):8354-9.
Zimmermann H, Koytchev R, Mayer O, Borner A, Mellinger U, Breitbarth H. 1998.
Pharmacokinetics of orally administered oestradiol valerate. Results of a single-
dose cross-over bioequivalence study in postmenopausal women.
Arzneimittelforschung 48(9):941-947.